Related Experiment Videos
[Enteral nutrition with peri-surgery immunomodulating diet]
O Abdel-lah Fernández1, A Abdel-lah Mohamed, J Sánchez Fernánndez
1Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario Central de Asturias, España. bad@usuarios.retecal.es
Nutricion Hospitalaria
|December 13, 2005
Summary
Peri-surgical immunomodulating nutrition improved nutritional status in patients undergoing esophageal or gastric cancer surgery. Early enteral nutrition via jejunostomy was well-tolerated with low morbidity, aiding recovery.
Area of Science:
- Oncology
- Surgical Nutrition
- Gastroenterology
Context:
- Esophageal and gastric cancer patients undergoing major surgery (esophagectomy/gastrectomy) often experience significant nutritional compromise.
- Peri-operative nutritional status is critical for surgical outcomes and recovery in these vulnerable patients.
Purpose:
- To evaluate the peri-surgical nutritional status of patients with esophageal or gastric cancer.
- To determine the impact of an early enteral immunomodulating diet on post-surgical complications and recovery.
Summary:
- A study involving 68 patients (esophageal and gastric cancer) assessed nutritional parameters before and after surgery.
- Patients received an early enteral immunomodulating diet via jejunostomy, with nutritional markers monitored on days 5 and 10 post-surgery.
- Biochemical nutrition parameters generally decreased by day 5 but improved by day 10, indicating a positive response to nutrition interventions.
Impact:
- Peri-surgical immunomodulating nutrition appears to effectively restore post-surgical nutritional parameters.
- Early enteral nutrition through jejunostomy is well-tolerated and associated with low morbidity, supporting its use in enhancing recovery.
- Nutritional markers and clinical factors (cholesterol, CRP, IgM, comorbidities) can predict patient response and outcomes.